Literature DB >> 31767266

Synthesis of novel 4-Boc-piperidone chalcones and evaluation of their cytotoxic activity against highly-metastatic cancer cells.

Carlimar Ocasio-Malavé1, Metsiel J Donate2, María M Sánchez3, Jesús M Sosa-Rivera2, Joseph W Mooney1, Tomás A Pereles-De León1, Néstor M Carballeira4, Beatriz Zayas5, Christian E Vélez-Gerena5, Magaly Martínez-Ferrer2, David J Sanabria-Ríos6.   

Abstract

In this study, six curcuminoids containing a tert-butoxycarbonyl (Boc) piperidone core were successfully synthesized, five of them are novel compounds reported here for the first time. These compounds were prepared through an aldolic condensation by adding tetrahydropyranyl-protected benzaldehydes or substituted benzaldehyde to a reaction mixture containing 4-Boc-piperidone and lithium hydroxide in an alcoholic solvent. A 44-94% yield was obtained supporting the developed methodology as a good strategy for the synthesis of 4-Boc-piperidone chalcones. Cytotoxic activity against LoVo and COLO 205 human colorectal cell lines was observed at GI50 values that range from 0.84 to 34.7 μg/mL, while in PC3 and 22RV1 human prostate cancer cell lines, GI50 values ranging from 17.1 to 22.9 μg/mL were obtained. Results from biochemical assays suggest that the cytotoxicity of the 4-Boc-piperidone chalcones can be linked to their ability to induce apoptosis, decrease the activity of NFκB and cellular proliferation. Our findings strongly support the potential of Boc-piperidone chalcones as novel cytotoxic agents against highly-metastatic cancer cells.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cancer; Cell proliferation; Curcumin; Curcumin analogs; Cytotoxic agents

Year:  2019        PMID: 31767266      PMCID: PMC7460386          DOI: 10.1016/j.bmcl.2019.126760

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  44 in total

1.  Curcumin decreases specificity protein expression in bladder cancer cells.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Sudhakar Chintharlapalli; Sabitha Papineni; Roger Smith; Xiangrong Li; Stephen Safe
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

Review 2.  Curcumin as potential therapeutic natural product: a nanobiotechnological perspective.

Authors:  Soumitra Shome; Anupam Das Talukdar; Manabendra Dutta Choudhury; Mrinal Kanti Bhattacharya; Hrishikesh Upadhyaya
Journal:  J Pharm Pharmacol       Date:  2016-10-17       Impact factor: 3.765

3.  Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.

Authors:  Sita Aggarwal; Haruyo Ichikawa; Yasunari Takada; Santosh K Sandur; Shishir Shishodia; Bharat B Aggarwal
Journal:  Mol Pharmacol       Date:  2005-10-11       Impact factor: 4.436

4.  Acetylacetone-cleaving enzyme Dke1: a novel C-C-bond-cleaving enzyme from Acinetobacter johnsonii.

Authors:  Grit D Straganz; Anton Glieder; Lothar Brecker; Douglas W Ribbons; Walter Steiner
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

5.  Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis.

Authors:  Suksanti Prakobwong; Jarinya Khoontawad; Puangrat Yongvanit; Chawalit Pairojkul; Yusuke Hiraku; Paiboon Sithithaworn; Porntip Pinlaor; Bharat B Aggarwal; Somchai Pinlaor
Journal:  Int J Cancer       Date:  2010-11-03       Impact factor: 7.396

6.  Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells.

Authors:  Pei-Ying Chang; Shu-Fen Peng; Chao-Ying Lee; Chi-Cheng Lu; Shih-Chang Tsai; Tzong-Ming Shieh; Tian-Shung Wu; Ming-Gene Tu; Michael Yuanchien Chen; Jai-Sing Yang
Journal:  Int J Oncol       Date:  2013-08-05       Impact factor: 5.650

7.  Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers.

Authors:  Sheeja T Tharakan; Teruo Inamoto; Bokyung Sung; Bharat B Aggarwal; Ashish M Kamat
Journal:  Biochem Pharmacol       Date:  2009-08-12       Impact factor: 5.858

8.  Pyridine analogues of curcumin exhibit high activity for inhibiting CWR-22Rv1 human prostate cancer cell growth and androgen receptor activation.

Authors:  Dai-Ying Zhou; Su-Qing Zhao; Zhi-Yun DU; X I Zheng; Kun Zhang
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

9.  Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.

Authors:  Shruti U Gandhy; Kyounghyun Kim; Lesley Larsen; Rhonda J Rosengren; Stephen Safe
Journal:  BMC Cancer       Date:  2012-11-30       Impact factor: 4.430

Review 10.  A review on antibacterial, antiviral, and antifungal activity of curcumin.

Authors:  Soheil Zorofchian Moghadamtousi; Habsah Abdul Kadir; Pouya Hassandarvish; Hassan Tajik; Sazaly Abubakar; Keivan Zandi
Journal:  Biomed Res Int       Date:  2014-04-29       Impact factor: 3.411

View more
  1 in total

1.  Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents.

Authors:  Chao-Fan Lu; Sheng-Hui Wang; Xiao-Jing Pang; Ting Zhu; Hong-Li Li; Qing-Rong Li; Qian-Yu Li; Yu-Fan Gu; Zhao-Yang Mu; Min-Jie Jin; Yin-Ru Li; Yang-Yang Hu; Yan-Bing Zhang; Jian Song; Sai-Yang Zhang
Journal:  Molecules       Date:  2020-11-25       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.